Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
JACC. Heart Failure
|
January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort
Florian Rader, Artur Oręziak, Lubna Choudhury, et al.
JACC. Cardiovascular Imaging
|
September 10, 2024
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial
Milind Y Desai, Yuichiro Okushi, Kathy Wolski, et al.
Circulation
|
May 12, 2025
Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM
Milind Y Desai, Kathy Wolski, Anjali Owens, et al.
Circulation
|
November 18, 2024
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM
Milind Y Desai, Kathy Wolski, Anjali Owens, et al.
Circulation. Cardiovascular Imaging
|
September 2, 2024
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial
Milind Y Desai, Yuichiro Okushi, Andrew Gaballa, et al.
JAMA Cardiology
|
August 28, 2023
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial
Milind Y Desai, Anjali Owens, Kathy Wolski, et al.
Faraday Discussions
|
November 29, 2016
Reactions at the nanoscale: general discussion
Thom Hersbach, Julie MacPherson, Olaf Magnussen, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
December 29, 2024
Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions With Automated Assessments in Hypertrophic Cardiomyopathy: A Substudy From VALOR-HCM
Gary Parizher, Alice Haouzi, Wael A Jaber, et al.
Journal of the American College of Cardiology
|
September 4, 2024
Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial
Milind Y Desai, Anjali Owens, Kathy Wolski, et al.
Faraday Discussions
|
November 29, 2016
Nanopores: general discussion
Andrew Mount, Minkyung Kang, David Fermin, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
JACC. Heart Failure
|
January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE Cohort
Florian Rader, Artur Oręziak, Lubna Choudhury, et al.
JACC. Cardiovascular Imaging
|
September 10, 2024
Mavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial
Milind Y Desai, Yuichiro Okushi, Kathy Wolski, et al.
Circulation
|
May 12, 2025
Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM
Milind Y Desai, Kathy Wolski, Anjali Owens, et al.
Circulation
|
November 18, 2024
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM
Milind Y Desai, Kathy Wolski, Anjali Owens, et al.
Circulation. Cardiovascular Imaging
|
September 2, 2024
Serial Changes in Ventricular Strain in Symptomatic Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: Insights From the VALOR-HCM Trial
Milind Y Desai, Yuichiro Okushi, Andrew Gaballa, et al.
JAMA Cardiology
|
August 28, 2023
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 56 Results From the VALOR-HCM Randomized Clinical Trial
Milind Y Desai, Anjali Owens, Kathy Wolski, et al.
Faraday Discussions
|
November 29, 2016
Reactions at the nanoscale: general discussion
Thom Hersbach, Julie MacPherson, Olaf Magnussen, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
December 29, 2024
Limited Concordance of Left Ventricular Ejection Fraction and Chamber Dimensions With Automated Assessments in Hypertrophic Cardiomyopathy: A Substudy From VALOR-HCM
Gary Parizher, Alice Haouzi, Wael A Jaber, et al.
Journal of the American College of Cardiology
|
September 4, 2024
Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial
Milind Y Desai, Anjali Owens, Kathy Wolski, et al.
Faraday Discussions
|
November 29, 2016
Nanopores: general discussion
Andrew Mount, Minkyung Kang, David Fermin, et al.
Page
of 3